Skip to content

The Clinical Study on the Retention on Prism and COPD

The Clinical Study on the Retention Ratio of Impaired Pulmonary Function and Chronic Obstructive Pulmonary Disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106916
Enrollment
Unknown
Registered
2025-07-31
Start date
2024-12-10
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with symptoms such as cough and chest tightness, but with normal lung function test results: FEV1/FVC=70%, FEV1%pred and/or FVC%pred<80%

Interventions

PRISm group:drug
COPD group:Regular long-term inhalation drug therapy

Sponsors

Chengyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 40-80 years old; 2.Willing to participate in the study and to sign the informed consent form; 3.Complete the standard respiratory tract epidemiology questionnaire included in this study; 4.Lung function tests were completed for prebronchodilator and post-bronchodilator examinations;

Exclusion criteria

Exclusion criteria: 1.Subjects aged 80 years; 2.Respiratory tract infection or aggravation within 4 weeks before screening; 3.Psychosis, auditory hallucinations, visual hallucinations, or taking antipsychotic medication; 4.After lobectomy; 5.A heart attack within 3 months;

Design outcomes

Primary

MeasureTime frame
Lung function;

Countries

China

Contacts

Public ContactHuang Chunlei

Chengyang People's Hospital

289898681@qq.com+86 532 5800 0158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026